Iida, Hiroya
Miyake, Toru
Tani, Masaji
Tanaka, Takuya
Kawakami, Kayo
Ikuno, Yoshihiro
Mandai, Ryoichi
Shimizu, Tomoharu http://orcid.org/0000-0002-2858-0786
Article History
Received: 21 October 2020
Accepted: 30 November 2020
First Online: 10 December 2020
Ethics approval and consent to participate
: Edoxaban administration for PVT treatment was approved by the Intractable Diseases Treatment Technology and Unapproved Medication Assessment Management Office at the Shiga University of Medical Science Hospital. Informed consent was obtained from each patient.
: Informed consent for publication in this case report was obtained from the patients or their legal guardians regarding this case report.
: The authors declare that they have no competing interests.